Analysts have been eager to weigh in on the Technology sector with new ratings on Enfusion (ENFN – Research Report), Vertex (VERX – Research Report) and Shift4 Payments (FOUR – Research Report).
Enfusion (ENFN)
In a report released yesterday, Koji Ikeda from Bank of America Securities reiterated a Sell rating on Enfusion, with a price target of $9.00. The company’s shares closed last Thursday at $9.26.
According to TipRanks.com, Ikeda is a 5-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Enfusion with a $10.50 average price target.
See the top stocks recommended by analysts >>
Vertex (VERX)
Bank of America Securities analyst Bradley Sills reiterated a Hold rating on Vertex yesterday and set a price target of $34.00. The company’s shares closed last Thursday at $30.53.
According to TipRanks.com, Sills is a 4-star analyst with an average return of
Currently, the analyst consensus on Vertex is a Moderate Buy with an average price target of $37.00.
Shift4 Payments (FOUR)
Bank of America Securities analyst Jason Kupferberg maintained a Buy rating on Shift4 Payments yesterday and set a price target of $95.00. The company’s shares closed last Thursday at $61.03.
According to TipRanks.com, Kupferberg is a 3-star analyst with an average return of
Currently, the analyst consensus on Shift4 Payments is a Strong Buy with an average price target of $89.29, implying a 58.0% upside from current levels. In a report released yesterday, Goldman Sachs also maintained a Buy rating on the stock with a $80.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ENFN:
